Showing results (381-390 of 423) with videos related to

Sort By:
Pageof 43
BMC Pediatrics|July 20, 2014
The Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) studyIan M Paul, Jennifer S Williams, Stephanie Anzman-Frasca, et al.
Cancer|September 28, 2020
Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trialClayton B Hess, Zachary S Buchwald, William Stokes, et al.
Thorax|January 29, 2024
Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trialScott A Sands, Jinny Collet, Laura K Gell, et al.
Plos One|May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-VBryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Thorax|April 3, 2026
Atomoxetine plus oxybutynin for obstructive sleep apnoea: a randomised-controlled trial with detailed pathophysiologyLaura K Gell, Suzanne M Bertisch, Natalie V Lawrence, et al.
Cancer Research|November 14, 1997
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinaseJ D Moyer, E G Barbacci, K K Iwata, et al.
Medchemcomm|August 16, 2018
Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitorsBrian A Sparling, S Yi, J Able, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2017
Discovery of a biarylamide series of potent, state-dependent NaV1.7 inhibitorsLaurie B Schenkel, Erin F DiMauro, Hanh N Nguyen, et al.
Molecular and Cellular Biology|September 19, 1998
ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor networkR Pinkas-Kramarski, M Shelly, B C Guarino, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic miceV A Pollack, D M Savage, D A Baker, et al.
Pageof 43